The patients of esophageal cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer, colorectal cancer, ulcerative colitis, Crohn'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The patients of esophageal cancer, gastric cancer, hepatocellular carcinoma, pancreatic cancer, colorectal cancer, ulcerative colitis, Crohn's disease, intestinal Behcet's disease, Barrett esophagus, gastric adenoma, colorectal adenoma, functional dyspepsia. And healthy subjects who are performed endoscopy.
Exclusion criteria
Exclusion criteria: The patients with the artificial anus The patients who underwent the surgery for the intestinal tract within 12 weeks The patients who received antibiotics within four weeks before registration day The patients that an agreement is not obtained The patients that doctor attending judged an arrangement to this study to be inadequate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The difference of gastrointestinal microbiota between healthy control and each disease. | — |
Secondary
| Measure | Time frame |
|---|---|
| The correlation between the variation of gastrointestinal microbiota and condition of each disease. | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Department of Gastroenterology and Hepatology